Surgical Science Sweden AB (SUS) — Capital Reinvestment Ratio
Surgical Science Sweden AB (SUS) has a Capital Reinvestment Ratio of 0.09x as of December 2025, meaning it reinvests 0% of its operating cash flow (Skr72.89 Million) in capital expenditures (Skr6.24 Million). See how leveraged is Surgical Science Sweden AB's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Surgical Science Sweden AB Capital Reinvestment Ratio (2015–2025)
This chart tracks Surgical Science Sweden AB's Capital Reinvestment Ratio across 11 annual periods. Check how aggressively does Surgical Science Sweden AB reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Surgical Science Sweden AB (2015–2025)
Year-by-year Capital Reinvestment Ratio for Surgical Science Sweden AB from 2015 to 2025. For live market cap and broader valuation context, see Surgical Science Sweden AB market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | Skr79.80 Million | Skr11.68 Million | ▼ -57.7% |
| 2024 | 0.35x | Skr137.22 Million | Skr47.53 Million | ▲ +87.0% |
| 2023 | 0.19x | Skr238.29 Million | Skr44.13 Million | ▼ -30.6% |
| 2022 | 0.27x | Skr129.49 Million | Skr34.55 Million | ▼ -27.5% |
| 2021 | 0.37x | Skr39.08 Million | Skr14.38 Million | ▼ -1.7% |
| 2020 | 0.37x | Skr23.23 Million | Skr8.69 Million | ▲ +131.8% |
| 2019 | 0.16x | Skr55.20 Million | Skr8.91 Million | ▼ -87.1% |
| 2018 | 1.26x | Skr6.88 Million | Skr8.64 Million | ▼ -17.7% |
| 2017 | 1.53x | Skr7.94 Million | Skr12.12 Million | ▲ +74.8% |
| 2016 | 0.87x | Skr13.40 Million | Skr11.70 Million | ▼ -21.1% |
| 2015 | 1.11x | Skr7.50 Million | Skr8.30 Million | — |